Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide in Idiopathic Pulmonary Fibrosis
NCT00463983Phase 2Completed
- Sponsor
- Inserm
- Start
- Oct 2006
- Primary completion
- Jan 2010
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of octreotide in idiopathic pulmonary fibrosis (IPF), sponsored by Inserm. Started Oct 2006; status: completed.
02
Drugs
octreotide
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NCT00463983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00463983.